98 related articles for article (PubMed ID: 6423185)
21. A rare cause of diuretic refractory ascites.
Di Costanzo GG; Ragozzino A; Niola R; Maglione F; Ascione A
Gut; 2006 Jan; 55(1):53, 73. PubMed ID: 16344575
[No Abstract] [Full Text] [Related]
22. [Management of hepatic ascites using Fursemide].
Bemvenuti GA; Job JM
Hospital (Rio J); 1968 Nov; 74(5):1601-38. PubMed ID: 5305338
[No Abstract] [Full Text] [Related]
23. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
[TBL] [Abstract][Full Text] [Related]
24. Combined ascitic-fluid and furosemide infusion in the management of ascites.
Eknoyan G; Martinez-Maldonado M; Yium JJ; Suki WN
N Engl J Med; 1970 Mar; 282(13):713-7. PubMed ID: 5416204
[No Abstract] [Full Text] [Related]
25. [Postoperative infusion in patients with urinary calculi during comparative treatment with using mannitol and furosemide].
Wiederhold EM; Schneider HJ; Hesse A
Z Urol Nephrol; 1974 Feb; 67(2):99-109. PubMed ID: 4849436
[No Abstract] [Full Text] [Related]
26. Furosemide disposition in cirrhotic patients.
Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
[TBL] [Abstract][Full Text] [Related]
27. Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites.
Tuttolomondo A; Pinto A; Parrinello G; Licata G
Semin Nephrol; 2011 Nov; 31(6):513-22. PubMed ID: 22099508
[TBL] [Abstract][Full Text] [Related]
28. [Conservative treatment of ascites in patients with cirrhosis of the liver].
Hartleb J; Mazur W
Wiad Lek; 1989 Aug 15-Sep 15; 42(16-18):1000-5. PubMed ID: 2640068
[No Abstract] [Full Text] [Related]
29. A new approach for refractory oedema--pharmacological paracentesis.
Sonwalkar AV; Wechalekar MD; Wechalekar DK; Waikar SM; Bhala BB
J Assoc Physicians India; 1973 Jul; 21(7):585-8. PubMed ID: 4283774
[No Abstract] [Full Text] [Related]
30. Diuretics in malignant effusions and edemas of generalized cancer.
Razis DV; Athanasiou A; Dadiotis L
J Med; 1976; 7(6):449-61. PubMed ID: 1070516
[TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
Castagnolo B; De Colibus V; Napolitano L; Aliperta A; Caldarelli G; Abignente F
Clin Ter; 1977 Dec; 83(6):625-9. PubMed ID: 343976
[No Abstract] [Full Text] [Related]
32. [Treatment of ascites in hepatic cirrhosis].
Arroyo JL; Bueno J; Rivero A; Lucas I; Ortiz de Landazuri E
Rev Esp Enferm Apar Dig; 1966 Nov; 25(9):1021-46. PubMed ID: 5997895
[No Abstract] [Full Text] [Related]
33. Refractory ascites: can it be defined only by the response to furosemide and spironolactone?
Kalambokis G; Tsianos EV
Liver Int; 2010 Oct; 30(9):1394; author reply 1395-6. PubMed ID: 20738777
[No Abstract] [Full Text] [Related]
34. Dopamine-frusemide therapy in acute renal failure.
Graziani G; Casati S; Cantaluppi A; Citterio A; Aroldi A; Scalamogna A; Brancaccio D; Ponticelli C
Proc Eur Dial Transplant Assoc; 1983; 19():319-24. PubMed ID: 6878248
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic ascites: treatment by continuous somatostatin infusion.
Gislason H; Grønbech JE; Søreide O
Am J Gastroenterol; 1991 Apr; 86(4):519-21. PubMed ID: 1672789
[TBL] [Abstract][Full Text] [Related]
36. Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.
Brater DC; Chalasani N; Gorski JC; Horlander JC; Craven R; Hoen H; Maya J
Trans Am Clin Climatol Assoc; 2001; 112():108-15; discussion 116. PubMed ID: 11413770
[No Abstract] [Full Text] [Related]
37. [Refractory ascites: concept and therapeutic possibilities].
Lissen Otero E; Leal Noval M; Lozano de León-Naranjo F; Sánchez Quijano A; Peláez Domínguez S; Miranda Guisado ML; Relimpio Ferrer F; Andreu Kern F
Med Clin (Barc); 1983 Jan; 80(1):24-30. PubMed ID: 6339835
[No Abstract] [Full Text] [Related]
38. [Hepatic cirrhosis with refractory ascitis and changes in renal function: effects of the infusion of fresh plasma and furosemide].
Bardi A; Orozco R; Sapunar J; Fernández I
Rev Med Chil; 1989 Jul; 117(7):740-6. PubMed ID: 2519427
[TBL] [Abstract][Full Text] [Related]
39. Ascites formation and dynamics in cirrhotic patients.
Gentilini P
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):749-51. PubMed ID: 7496863
[No Abstract] [Full Text] [Related]
40. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
Fuller RK; Khambatta PB; Gobezie GC
JAMA; 1977 Mar; 237(10):972-5. PubMed ID: 319263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
